300406.SZ

Sep 17, 2026, 09:48 UTC

Beijing Strong Biotechnologies plans to subscribe to 26,212 yuan of newly added registered capital in its associate Zhongke Natai at 1 yuan per yuan of registered capital as part of Zhongke Natai's equity restructuring, and to waive its repurchase right and right of first refusal under the 2021 shareholders' agreement, raising its stake from 5.1387% to 6.3520%.